111 related articles for article (PubMed ID: 8478147)
1. Expression of P-cadherin in gastric carcinomas and its reduction in tumor progression.
Yasui W; Sano T; Nishimura K; Kitadai Y; Ji ZQ; Yokozaki H; Ito H; Tahara E
Int J Cancer; 1993 Apr; 54(1):49-52. PubMed ID: 8478147
[TBL] [Abstract][Full Text] [Related]
2. Expression of Beta-1 integrin in human gastric carcinomas - correlation with histological type and tumor progression.
Kozako Y; Yasui W; Tahara E
Int J Oncol; 1994 Aug; 5(2):225-30. PubMed ID: 21559579
[TBL] [Abstract][Full Text] [Related]
3. Expression of e-cadherin, alpha-catenins and Beta-catenins in human gastric carcinomas - correlation with histology and tumor progression.
Yasui W; Kuniyasu H; Akama Y; Kitahara K; Nagafuchi A; Ishihara S; Tsukita S; Tahara E
Oncol Rep; 1995 Jan; 2(1):111-7. PubMed ID: 21597700
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of undifferentiated-type gastric carcinoma.
Tamura G; Sato K; Akiyama S; Tsuchiya T; Endoh Y; Usuba O; Kimura W; Nishizuka S; Motoyama T
Lab Invest; 2001 Apr; 81(4):593-8. PubMed ID: 11304579
[TBL] [Abstract][Full Text] [Related]
5. Gastric and intestinal phenotypic cell marker expressions in gastric differentiated-type carcinomas: association with E-cadherin expression and chromosomal changes.
Morohara K; Tajima Y; Nakao K; Nishino N; Aoki S; Kato M; Sakamoto M; Yamazaki K; Kaetsu T; Suzuki S; Tsunoda A; Tachikawa T; Kusano M
J Cancer Res Clin Oncol; 2006 Jun; 132(6):363-75. PubMed ID: 16447040
[TBL] [Abstract][Full Text] [Related]
6. [CpG island methylation of E-cadherin gene promoter in gastric carcinoma].
Zhou YN; Xu CP; Han B; Ji R
Ai Zheng; 2005 Oct; 24(10):1220-4. PubMed ID: 16219136
[TBL] [Abstract][Full Text] [Related]
7. Expression of E- and P-cadherin in gastric carcinomas.
Shimoyama Y; Hirohashi S
Cancer Res; 1991 Apr; 51(8):2185-92. PubMed ID: 2009537
[TBL] [Abstract][Full Text] [Related]
8. Association of HER1 amplification with poor prognosis in well differentiated gastric carcinomas.
Kandel C; Leclair F; Bou-Hanna C; Laboisse CL; Mosnier JF
J Clin Pathol; 2014 Apr; 67(4):307-12. PubMed ID: 24218028
[TBL] [Abstract][Full Text] [Related]
9. E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas.
Tamura G; Yin J; Wang S; Fleisher AS; Zou T; Abraham JM; Kong D; Smolinski KN; Wilson KT; James SP; Silverberg SG; Nishizuka S; Terashima M; Motoyama T; Meltzer SJ
J Natl Cancer Inst; 2000 Apr; 92(7):569-73. PubMed ID: 10749913
[TBL] [Abstract][Full Text] [Related]
10. P-cadherin expression in gastric carcinoma: its regulation mechanism and prognostic significance.
Kim MA; Jung EJ; Lee HS; Lee HE; Yang HK; Oh DY; Bang YJ; Kim WH
Hum Pathol; 2010 Jun; 41(6):877-85. PubMed ID: 20233621
[TBL] [Abstract][Full Text] [Related]
11. Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer.
Yonemura Y; Endou Y; Kimura K; Fushida S; Bandou E; Taniguchi K; Kinoshita K; Ninomiya I; Sugiyama K; Heizmann CW; Schafer BW; Sasaki T
Clin Cancer Res; 2000 Nov; 6(11):4234-42. PubMed ID: 11106237
[TBL] [Abstract][Full Text] [Related]
12. Expression level of microRNA-200c is associated with cell morphology in vitro and histological differentiation through regulation of ZEB1/2 and E-cadherin in gastric carcinoma.
Kurata A; Yamada M; Ohno SI; Inoue S; Hashimoto H; Fujita K; Takanashi M; Kuroda M
Oncol Rep; 2018 Jan; 39(1):91-100. PubMed ID: 29138864
[TBL] [Abstract][Full Text] [Related]
13. Expression of mucins and E-cadherin in gastric carcinoma and their clinical significance.
Zhang HK; Zhang QM; Zhao TH; Li YY; Yi YF
World J Gastroenterol; 2004 Oct; 10(20):3044-7. PubMed ID: 15378790
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic evaluation of immunohistochemical E-cadherin expression in human gastric carcinomas.
Shino Y; Watanabe A; Yamada Y; Tanase M; Yamada T; Matsuda M; Yamashita J; Tatsumi M; Miwa T; Nakano H
Cancer; 1995 Dec; 76(11):2193-201. PubMed ID: 8635021
[TBL] [Abstract][Full Text] [Related]
15. Modulation of E-cadherin by hepatocyte growth factor induces aggressiveness of gastric carcinoma.
Han SU; Lee HY; Lee JH; Kim WH; Nam H; Kim H; Cho YK; Kim MW; Lee KU
Ann Surg; 2005 Nov; 242(5):676-83. PubMed ID: 16244541
[TBL] [Abstract][Full Text] [Related]
16. Significance of dysadherin and E-cadherin expression in differentiated-type gastric carcinoma with submucosal invasion.
Maehata Y; Hirahashi M; Aishima S; Kishimoto J; Hirohashi S; Yao T; Takashima H; Tsuneyoshi M; Oda Y
Hum Pathol; 2011 Apr; 42(4):558-67. PubMed ID: 21239043
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer.
Rosivatz E; Becker I; Specht K; Fricke E; Luber B; Busch R; Höfler H; Becker KF
Am J Pathol; 2002 Nov; 161(5):1881-91. PubMed ID: 12414534
[TBL] [Abstract][Full Text] [Related]
18. Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival.
Zhou YN; Xu CP; Han B; Li M; Qiao L; Fang DC; Yang JM
World J Gastroenterol; 2002 Dec; 8(6):987-93. PubMed ID: 12439911
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of expression of proliferating cell nuclear antigen and E-cadherin in gastric carcinoma.
Hu L; Li HL; Li WF; Chen JM; Yang JT; Gu JJ; Xin L
World J Gastroenterol; 2017 May; 23(20):3721-3729. PubMed ID: 28611525
[TBL] [Abstract][Full Text] [Related]
20. Expression of E-cadherin in human gastric carcinomas.
Shino Y; Nakatani K; Watanabe A; Okumura T; Yamada Y; Yamada Y; Yano T; Nakano H
Gastroenterol Jpn; 1991 Apr; 26(2):231. PubMed ID: 2040405
[No Abstract] [Full Text] [Related]
[Next] [New Search]
